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Microglia are the resident macrophages in the central nervous system (CNS) and play
essential roles in neuronal homeostasis and neuroinflammatory pathologies. Recently,
microglia have been shown to contribute decisively to neuropathologic processes
after ischemic stroke. Furthermore, natural compounds have been reported to
attenuate inflammation and pathologies associated with neuroinflammation. Tryptanthrin
(indolo[2,1-b]quinazoline-6,12-dione) is a phytoalkaloid with known anti-inflammatory
effects in cells. In present study, the authors confirmed middle cerebral artery occlusion
(MCAO) injury triggers the activation of microglia in brain tissue, and investigated
whether tryptanthrin influences the function of mouse murine BV2 microglia under
LPS-induced inflammatory conditions in vitro. It was found tryptanthrin protected
BV2 microglia cells against LPS-induced inflammation and inhibited the induction
of M1 phenotype microglia under inflammatory conditions. In addition, tryptanthrin
reduced the production of pro-inflammatory cytokines in BV2 microglia cells via nuclear
factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase 1 (HO-1) signaling and
NF-κB signaling. The authors suggest that tryptanthrin might alleviate the progress
of neuropathologies by controlling microglial functions under neuroinflammatory
conditions.
Keywords: tryptanthrin, BV2 microglia cells, ischemic stroke, inflammation, nuclear factor erythroid 2-related
factor 2 (Nrf2), heme oxygenase 1 (HO-1), nuclear factor-kappaB (NF-κB)
INTRODUCTION
Microglia are a type of mononuclear macrophage (Butovsky et al., 2012; Prinz and Priller,
2014) and are the main macrophages involved in inflammatory response in the central nervous
system (CNS; Graeber and Streit, 2010), and reportedly, are important regulators of homeostasis
and neuroinflammation (Cianciulli et al., 2016). Under stressful conditions, such as, in the
presence of infection or inflammation, microglia are activated (Graeber and Streit, 2010), and
secrete a variety of inflammatory mediators, such as, tumor necrosis factor-alpha (TNF-α),
and interleukin (IL)-10, and mediators of inflammation, such as, reactive oxygen species (ROS),
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nitric oxide (NO) and prostaglandin E2 (PGE2; Streit et al.,
2004; More et al., 2013). Accordingly, their activities are linked
to the pathologies of numerous CNS diseases and conditions,
such as, ischemic stroke (Mach et al., 1999; Hanisch and
Kettenmann, 2007). When activated, microglia exhibit different
phenotypes and perform different physiological roles (Boche
et al., 2013; Cherry et al., 2014). The intracellular dynamics of
microglia can be classified as M1 phenotype, which upregulates
pro-inflammatory mediators (Gordon and Martinez, 2010),
or as M2 phenotype, which upregulates anti-inflammatory
mediators (Benarroch, 2013; Tang and Le, 2016). M1 microglia
activation has been suggested to contribute to progressive
tissue damage, leading to chronic neurodegeneration (Qin
et al., 2013; Wang et al., 2013; Loane et al., 2014), whereas,
M2 microglia activation has been reported to regulate wound
healing and attenuate inflammation, and thus, contribute to
tissue repair and regeneration (Cherry et al., 2014). In-ammation
occurs throughout the progression of ischemic stroke and
plays a crucial role in the neuropathological process (Picascia
et al., 2015). After ischemic stroke, microglia retract finer
processes (Kettenmann et al., 2011) and begin to produce
inflammatory cytokines (Thored et al., 2009). Several studies
have reported microglial activation in the penumbra area
after middle cerebral artery occlusion (MCAO) injury (Rupalla
et al., 1998; Ito et al., 2001; Perego et al., 2011). In recent
years, to ameliorate pathology after stroke, many researchers
have tried to regulate microglia function and changes in
microglia phenotype during inflammatory conditions using
various substances (Song et al., 2014; Zhang et al., 2015;
Shu et al., 2016). Tryptanthrin (6,12-dihydro-6,12-dioxoindolo-
(2,1-b)-quinazoline) is a natural alkaloid found in P. tinctorium
(Honda et al., 1980; Scovill et al., 2002), and has been reported to
have various pharmacological effects, such as, anti-inflammatory
(Recio et al., 2006; Iwaki et al., 2011), antimicrobial (Honda
et al., 1979) and anti-tumor effects (Kimoto et al., 2001; Yu
et al., 2007, 2009; Liao et al., 2013). Tryptanthrin has also
been reported to suppress NO and prostaglandin E synthesis
in macrophages exposed to oxidative stress (Ishihara et al.,
2000). In present study, we investigated whether tryptanthrin
affects the phenotype and function of BV2 microglial cell
line, which has been used as a common microglia cell line,
under inflammatory conditions. Initially, we confirmed MCAO
injury triggers the activation of microglia in brain tissue,
and then sought to determine whether tryptanthrin influences
the function of microglia under LPS-induced inflammatory
conditions in vitro.
MATERIALS AND METHODS
MCAO Mouse Model
To study the effect of stroke on brain tissue, we used MCAO
mouse model. Male C57BL/6 mice (Orient, GyeongGi-Do,
Korea; 8 weeks old) were used in this study. Mice were
anesthetized with 5% isoflurane and then maintained with
2% isoflurane in 30% oxygen and 70% nitrous oxide by a
face mask onto homeothermic blanket for maintaining rectal
temperature 37 ± 0.5◦C. Mice were subjected to transient focal
cerebral ischemia by blocking middle cerebral artery with a
6–0 nylon suture. After 60 min of MCAO, blood flow was
restored by withdrawing the suture, and cerebral blood flow was
monitored using a Doppler flow meter (Transonic Systems, Inc.,
Ithaca, NY, USA). After reperfusion for 8 h, Zoletil mixture
(30 mg/kg; Virvac Laboratories, Carros, France) was injected
intraperitoneally. Mice were cardiac-perfused with saline and
brains were extracted. All animal care and experimental
procedures were conducted in accordance with the guidance for
animal experiments established by the Yonsei University. The
animals were housed in an air-conditioned room at 25◦C with
a 12 h dark/light cycle. All animals received human care with
unlimited access to chow and water.
Cell Culture and Drug Treatment
To check the tryptanthrin’s effect on microglia, we used mouse
murine BV2 microglial cells. BV2 microglia cells were cultured
in Dulbecco Modified Eagle Medium (DMEM; Gibco, Grand
Island, NY, USA) supplemented with 100 µg/ml penicillin-
streptomycin (Gibco, Grand Island, NY, USA) and 10% fetal
bovine serum (Gibco, Grand Island, NY, USA) at 37◦C in
5% CO2 incubator. For all experiments, cells were grown to
80%–90% confluency and then subjected to no more than
20 cell passages. Tryptanthrin was purchased from Sigma-
Aldrich (St. Louis, MO, USA). Protoporphyrin IX (Snpp; as
an inhibitor of heme oxygenase 1, HO-1) was purchased from
Porphyrin Products (Logan, UT, USA). BV2 cells were serum-
starved for 4 h, and then treated with tryptanthrin for 1 h prior
to the addition of LPS (1 µg/ml), and the cells were further
incubated for the next 8 h. On the other hand, other BV2 cells
were first treated with 50 nM SnPP for 30 min, tryptanthrin (20
µM) for 1 h and then exposed to LPS (1 µg/ml) for 8 h.
3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide
(MTT) Assay
BV2 microglia cells were plated at 1 × 104 cells/well in
96-well plates. After incubation for 1 day, cells were treated
with either dimethyl sulfoxide (DMSO) as the control or
with various concentration (0.1–50 µM) of tryptanthrin. The
final concentration of DMSO in the medium was 0.1% and
DMSO had no effect on cell viability. After exposure to
tryptanthrin for 24 h, viable cells were stained with 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT;
Sigma-Aldrich, St. Louis, MO, USA) solution (2 mg/ml in
PBS). After 3 h of incubation, medium was removed, and
100 µl of DMSO was added to solubilize the formazan
crystals. The absorbance was measured at 570 nm using a
multimode microplate reader (Tecan, Research Triangle Park,
NC, USA). The analysis was conducted in triplicate. Cell
viabilities were defined relative to control cells (considered
to be 100%).
Determination of Nitrite
BV2 microglia cells were plated onto 96-well plates, pre-treated
with different concentrations of tryptanthrin (0.1–20 µM) for
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FIGURE 1 | Expression levels of CD68, inducible NO synthase (iNOS), p-NF-κB and IκBα in mouse brain tissues. (A) Levels of CD68 (a marked of activated
microglia) in brain tissues were assessed immunohistochemically. Images show CD68-positive cells (green) in the cortex of middle cerebral artery occlusion (MCAO)
mice. CD68 expression was considerably higher in cortex in the 8 h MCAO mouse brain than in the control mouse brain. In addition, CD68-positive cells were
observed in ischemic striatum. (B) A plot of CD68-positive cell percentages. Results are expressed as means ± SDs. Each experiment conducted 3 mice per
conditions. Significant vs. normal, ∗p < 0.05 (paired T-Test with MCAO mice. (C) The protein levels of iNOS, p-NF-κB and IκBα in brain. Data are expressed as
mean ± SDs, and each experiment conducted three repeats per conditions. Significant vs. normal, ∗∗∗p < 0.001. Scale bar = 50 µm, CD68: green,
4′,6-diamidino-2-phenylindole (DAPI): blue, Nor: normal control group, MCAO: reperfusion 8 h after MCAO injury.
1 h, and then stimulated with 1 µg/ml of LPS. Supernatants
were collected and assayed for NO production by adding
Griess reagent (100 µl/well) and incubating for 15 min at
room temperature. Supernatant absorbance was measured at
540 nm using amicroplate reader (Versamax,Molecular Devices;
Cendan et al., 1996; Mazzio et al., 2016).
Cytokine Assay (ELISA Assay)
BV2microglia cells were plated in 6-well plates (5× 105 cells/ml)
and incubated with tryptanthrin in the presence of LPS for 24 h.
Cell-free supernatants were then collected, and IL-6 and TNF-α
levels were measured using a BD OptEIATM Mouse IL-6 ELISA
Kit (BD Biosciences, San Diego, CA, USA, Cat No 550950) or
a Cymax Mouse TNF-α ELISA kit (AbFrontier, Seoul, Korea,
Cat No LF-EK0275), respectively. Absorbances at 450 nm were
measured using an ELISA microplate reader.
Western Blot Analysis
BV2 microglia cells were washed rapidly with ice-cold PBS,
scraped, and collected. BV2 cell pellets were lysed with ice-cold
RIPA buffer (Thermo Scientific, Rockford, IL, USA) containing
protease/phosphatase inhibitor cocktail (GenDEPOT, Barker,
TX, USA). The lysates were centrifuged at 13,000 rpm for
30 min at 4◦C to produce whole-cell extracts, and protein
concentrations were then assessed using a bicinchoninic acid
(BCA) assay. Proteins (30 µg) were separated on 10%
SDS-polyacrylamide gel and transferred onto polyvinylidene
difluoride (PVDF) membranes (Millipore, Bedford, MA, USA).
After blocking with skim milk prepared in TBS/Tween (20 mM
Tris (pH 7.2), 150 mM NaCl, 0.1% Tween 20) for 1 h at
room temperature, immunoblots were incubated for 18 h
at 4◦C with primary antibodies that specifically detected
cyclooxygenase-2 (COX-2; M19; sc-1747-R) Rabbit polyclonal
(1:1000; Santa Cruz Biotechnology, Santa Cruz, CA, USA;
Almada et al., 2016), inducible NO synthase (iNOS; AB5382)
Rabbit polyclonal (1:1000; EMD Millipore, Temecula, CA,
USA; Stansley et al., 2012), HO-1 (A-3; sc-136960) mouse
monoclonal (1:1000, Santa Cruz Biotechnology; Almada et al.,
2016), or β-actin (C4; sc-47778) mouse monoclonal (1:2000;
Santa Cruz Biotechnology; Wang et al., 2016). Brain tissues
were lysed with ice-cold RIPA buffer (Thermo Scientific,
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FIGURE 2 | Effects of tryptanthrin on cell viability, nitric oxide (NO) production, and on the expressions of iNOS and COX-2. (A) Cell viability of
tryptanthrin treated microglia. BV2 microglia cells were treated with tryptanthrin at 0.1, 1, 10, 20, or 50 µM for 24 h. At concentrations below 50 µM tryptanthrin
treatment resulted in cell viabilities of >90%, and at 50 µM cell viability was ∼60%. Results are expressed as means ± SDs. Significant vs. control, ∗∗∗p < 0.001
(ANOVA analysis). (B) Nitrite production by LPS treated microglia was measured using Griess reagent. Significant vs. control, ###p < 0.001; significant vs. LPS,
∗p < 0.05, ∗∗∗p < 0.001 (ANOVA analysis). (C) Western blotting showed that the protein levels of iNOS and COX-2 were considerably higher in LPS treated
BV2 microglia than in non-treated controls. Furthermore, tryptanthrin pre-treatment reduced LPS-induced increases in iNOS and COX-2 protein levels. β-actin was
used as an internal control. Each experiment conducted three repeats per conditions. Significant vs. control, ###p < 0.001; significant vs. LPS, ∗p < 0.05,
∗∗p < 0.01, ∗∗∗p < 0.001 (ANOVA analysis). TT, tryptanthrin.
Rockford, IL, USA) containing protease/phosphatase inhibitor
cocktail (GenDEPOT, Barker, TX, USA), and supernatants
were centrifuged at 13,000 rpm for 1 h 30 min at 4◦C.
Proteins (30 µg) were separated on 10% SDS gel and
transferred to PVDF membranes. After blocking for 1 h at
room temperature, immunoblots were incubated for 12 h
at 4◦C with primary antibodies that specifically detected
iNOS (AB5382) Rabbit polyclonal (1:1000; EMD Millipore,
Temecula, CA, USA; Stansley et al., 2012), IkBα (L35A5;
#4814) mouse monoclonal (1:1000, Cell Signaling, Danvers,
MA, USA; Horvath et al., 2008), or p-NF-κB (Ser276; #3037)
Rabbit polyclonal (1:500, Cell Signaling, Danvers, MA, USA;
Henn et al., 2009). Blots were then incubated with each
secondary antibody (Cell Signaling, Danvers, MA, USA) for
1 h at room temperature. Blots were visualized by ECL
(Amersham Biosciences, Piscataway, NJ, USA). Equal loading
of proteins was verified by actin immunoblottings. At least
three separate experiments were performed to confirm changes.
Band intensities were quantified using ImageJ 1.42 software
(NIH Bethesda, MD, USA). Band densitometry was analyzed
by arbitrarily drawing a rectangular box around the selected
protein bands of interest. The equal sized rectangular box
was used to measure all bands of interest and background-
subtracted density of each peak of interest is quantified. All
densitometry data are normalized to the respective band intensity
of the β-actin loading controls. Nuclear and cytosolic fractions
were prepared using NE-PERTM Nuclear and Cytoplasmic
Extraction Reagents (Thermo Scientific, Rockford, IL, USA)
according to the manufacturer’s instructions. Briefly, cells
were lysed in ice-cold CER-I buffer supplemented with
protease inhibitors and incubated on ice for 10 min. After
addition of ice-cold CER-II, samples were centrifuged and
the supernatant solution (cytoplasmic fraction) was collected.
Pellets containing nuclei were washed three times in PBS to
remove contamination of cytosolic proteins and nuclear proteins
were extracted in NER buffer supplemented with protease
inhibitors.
Immunocytochemistry
BV2 microglial cells onto the coated glass were fixed with
4% paraformaldehyde (PFA) for 30 min and washed three
times with PBS. BV2 cells were permeabilized with 0.3%
Triton X-100 in PBS for 15 min, and blocked with 5%
bovine serum albumin (BSA) for 1 h. And then, samples
were incubated with primary antibodies overnight at 4◦C.
The following primary antibodies were used: anti-mouse CD68
(1:500, Santa Cruz Biotechnology, Santa Cruz, CA, USA;
Blasi et al., 1990), anti-goat p-NF-κB (1:500, Cell Signaling,
Danvers, MA, USA; Henn et al., 2009), and anti-mouse nuclear
factor erythroid 2-related factor 2 (Nrf2; 1:500, Santa Cruz
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FIGURE 3 | CD68 expression in LPS-treated BV2 microglia.
Immunocytochemistry was used to investigate the expression of CD68
(a marker of microglia activation). CD68 expression was higher in LPS treated
BV2 microglia than in non-treated controls, and tryptanthrin pretreatment
attenuated this LPS-induced expression. Scale bar: 50 µm,
4′,6-diamidino-2-phenylindole (DAPI): blue, CD68: green, Con, normal control
group; LPS, LPS (1 µg/ml) treatment group; TT, tryptanthrin.
Biotechnology, Santa Cruz, CA, USA; Zhang et al., 2016). After
incubation, cells were washed three times for 3 min with
PBS, incubated with each secondary antibody for 1 h at
room temperature, and counterstained with 1 µg/ml 4′,6-
diamidino-2-phenylindole (DAPI, 1:200, Invitrogen, Carlsbad,
CA, USA; Smolewski et al., 2001) for 15 min at room
temperature. Cells were imaged under a Zeiss LSM 710 confocal
microscope (Carl Zeiss, Thornwood, NY, USA; Cheon et al.,
2016). The images were acquired with objective lens of
40× as composites. Immunofluorescence was observed at
Excitation/Emission (nm; 358/463) for DAPI, (495/517) for
FITC, and (551/573) for Rhodamine by smart setup system
in ZEN microscope and Imaging software (Zeiss LSM 710,
Carl Zeiss, Oberkochen, Germany). Nrf2 immunoreactivity
was measured using ImageJ (ImageJ, Bethesda, MD, USA)
by analyzing the mean intensity of images obtained from
single confocal planes average intensity and applying a manual
selected threshold above the background intensity. Mean
intensity of p-NF-κB immunoreactivity was analyzed in Z-stack
average intesity by using Zen 2010 software from Carl Zeiss.
Nuclear p-NF-κB was identified by its colocalization with
DAPI staining while no colocalizing p-NF-kB was considered
cytosolic. Immunofluorescent intensity for p-NF-κB indicated
Mean intensity of three slice of projection.
Immunohistochemistry
Twenty-micrometer-thick frozen brain sections were cut
onto clean glass slides (Thermo Scientific, Waltham, MA,
USA), air-dried, and subsequently post-fixed in acetone for
15 min at −20◦C. The slides were first washed in PBS and
dipped into −20◦C ethyl alcohol for 20 min, incubated with
0.3% Trion X-100 which diluted in PBS. After blocking
nonspecific labeling, sections were incubated in 5% BSA
(Sigma-Aldrich, St. Louis, MO, USA) diluted in PBS for
30 min, and then primary and secondary antibodies were
added. Primary antibodies for CD68 (1:50, Santa Cruz
Biotechnology, Santa Cruz, CA, USA; Blasi et al., 1990)
were applied to samples overnight at 4◦C, and incubated for
2 h in the dark at room temperature with FITC-conjugated
anti-mouse Ig secondary antibody (1:100, Invitrogen, Carlsbad,
CA, USA). The sections again washed three times in PBS.
Sections were counterstained with 1 µg/ml DAPI (Invitrogen,
Carlsbad, CA, USA; Smolewski et al., 2001) and examined
under a confocal microscope (Zeiss LSM 710, Carl Zeiss,
Oberkochen, Germany). The images were acquired with
objective lens of 40× as composites. Immunofluorescence
was observed at Excitation/Emission (nm; 358/463) for
DAPI and (495/517) for FITC by smart setup system in
ZEN microscope and Imaging software (Carl Zeiss). Three
optical fields in a 150 × 150 µm of the striatum and cortex
(Bregma 0.62 mm) were randomly chosen under a 40×
objective from each sample for quantification (Supplementary
Figure S1). The percentage of positive cells for CD68 was
measured by ImageJ (ImageJ, Bethesda, MD, USA) program.
The minimal number of cells counted per mouse was
100. The percentage of CD68 positive cells was calculated
dividing the total number of CD68 positive cells by the
total number of DAPI stained cells observed in the same
field.
Statistical Analysis
Results are presented as mean ± standard deviations (SDs).
Statistical significances were determined using one-way analysis
of variance (ANOVA) followed by Turkey’s multiple comparison
and Student’s t-test. All experiments were independently
conducted at least three times. Data were analyzed with
Prism 5.0 software (GraphPad Software, Inc., San Diego,
CA, USA), and statistical significance was accepted for
p values< 0.05.
RESULTS
MCAO Injury Triggered the Activation of
Microglia in Brain
To examine microglia activation in mouse brain tissues, we
checked the expression of CD68 (Song and Lee, 2015) by
immunostaining (Figure 1A). Figure 1B showed the positive
cells percentage of CD68 (Figure 1B). These data showed that
MCAO resulted in microglia activation in brain cortex and
striatum (Figures 1A,B). Supplementary Figure S1 showed
the position of brain for immunostaining (Supplementary
Figure S1).
MCAO Injury Promoted Inflammatory
Signaling in Brain
To examine inflammatory signaling, we measured the
protein levels of iNOS and of phosphorylated NF-κB in
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FIGURE 4 | NF-κB activation in tryptanthrin pretreated BV2 microglia. (A) Western blotting showed the protein level of p-NF-κB p65 was increased by treating
naïve cells with LPS, but that tryptanthrin pretreatment inhibited this LPS-induced increase. β-actin was used as a loading control. (B) Ratio of p-NF-κB
(nucleus/cytoplasm) was measured by Zen program (Zen program, Oberkochen, Germany). This showed the translocation ratio of NF-κB into nucleus. (C) NF-κB
activation was assessed immunocytochemically. The image shows the nuclear translocation of NF-κB p65 in LPS-treated BV2 microglia as compared with
non-treated controls. Tryptanthrin (20 µM) pretreatment inhibited the LPS-induced nuclear translocation of NF-κB p65. Results are expressed as means ± SDs.
Each experiment conducted four repeats per conditions. Significant vs. control, ##p < 0.05, ###p < 0.001; significant vs. LPS, ∗∗p < 0.01 (ANOVA analysis).
Con, non-treated control; TT, tryptanthrin; 4′,6-diamidino-2-phenylindole (DAPI): blue, p-NF-κB: red.
MCAO mouse brain tissues (Figure 1C). It was found the
protein levels of iNOS and phosphorylated NF-κB were
substantially increased in MCAO mouse brain tissue as
compared with normal brain tissue (Figure 1C). In addition,
the protein levels of IκBα, which binds with NF-κB in
cytosol to inhibit the activation of NF-κB (Forman et al.,
2016), were significantly lower in MCAO mouse brain
tissue than in normal brain tissue (Figure 1C). These
observations show that MCAO injury activates iNOS and
NF-κB signaling.
Tryptanthrin Reduced the Production of
Nitric Oxide (NO) and Attenuated
Inflammatory Signaling in BV2 Microglia
Under Inflammatory Conditions
To assess the cellular toxicity of tryptanthrin, we measured the
cell viability of BV2 microglia cells treated with tryptanthrin
for 24 h using a MTT assay (Figure 2A). Our results showed
tryptanthrin did not affect cell viability at concentrations
of 0 µM to 20 µM (Figure 2A). In addition, we found
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FIGURE 5 | Effects of tryptanthrin on LPS-induced cytokine production
in BV2 microglia. (A) LPS-induced tumor necrosis factor-alpha (TNF)-α
production and (B) LPS-induced interleukin (IL)-6 production were also
reduced by pretreating cells with tryptanthrin. Each experiment conducted
four repeats per conditions. Significant vs. control, ###p < 0.001; significant
vs. LPS, ∗p < 0.05, ∗∗∗p < 0.001 (ANOVA analysis). Con, non-treated control.
that NO production was increased in BV2 microglia cells
after 8 h of LPS treatment (Figure 2B). To assess the
activations of iNOS and COX-2 inflammatory signals in
LPS treated BV2 microglia cells, we conducted western
blotting analysis (Figure 2C). Our results showed that the
protein levels of iNOS and COX-2 were markedly increased
in LPS treated BV2 microglia cells, and that tryptanthrin
pretreatment inhibited these increases (Figure 2C). At a
concentration of 20 µM, tryptanthrin induced marked decreases
in LPS-induced increases in iNOS and COX-2 protein levels
(Figure 2C).
Tryptanthrin Inhibited the Induction of
M1 Phenotype Microglia Under
Inflammatory Conditions
To determine whether tryptanthrin promotes phenotype
change of microglia under inflammatory conditions,
we observed the expression of mannose receptor CD68
(a marker of activated microglia) by immunostaining
(Figure 3). Our data indicated that LPS treatment increased
the expression of CD68 in BV2 microglia cells, and that
tryptanthrin pretreatment suppressed this increase (Figure 3).
Our western blotting data also showed that tryptanthrin
attenuated the LPS-induced phosphorylation of NF-κB p65
(Figure 4A). The phosphorylation of NF-κB was reduced by
tryptanthrin in LPS treated BV2 microglia (Figure 4A). To
confirm that tryptanthrin controls the activation of NF-kB
signaling in BV2 microglia, we checked the phosphorylation
and nuclear translocation of NF-κB p65 in tryptanthrin
pretreated BV2 microglia under LPS induced inflammatory
condition by immunostaining (Figures 4B,C). It was found
tryptanthrin suppressed the LPS-induced activation of NF-
κB (Figures 4A–C). To determine whether tryptanthrin
is involved in the secretion of cytokines by LPS treated
BV2 microglia, we assessed cytokine production by ELISA
(Figure 5). The productions of TNF-α and IL-6 were found
to be markedly reduced by tryptanthrin in LPS treated
BV2 microglia (Figure 5). Consequently, our results indicate
that tryptanthrin suppresses production of pro-inflammatory
cytokines in BV2 microglia under inflammatory conditions
(Figure 5).
Tryptanthrin Attenuated the Production of
NO and Cytokines through
Nrf2/HO-1 Signaling in LPS Treated
BV2 Microglia
To examine the activation of Nrf2/HO-1 signaling in LPS treated
microglia, we used immunocytochemistry (Figures 6A,B) and
western blotting (Figures 6C, 7). The expression of Nrf2 in LPS
treated BV2 microglia was lower than in normal BV2 microglia,
whereas tryptanthrin tends to induce the activation of Nrf2 in
inflammatory condition (Figures 6A,B). Figure 6C showed
treatment with tryptanthrin resulted in the nuclear translocation
of Nrf2 in the absence or presence of LPS (Figure 6C). To
confirm whether tryptanthrin regulates HO-1 induction in
BV2 microglia under inflammatory conditions, we checked
the induction of HO-1 in BV2 microglia by western blotting
(Figures 7A,B). The induction of HO-1 was evidently promoted
by tryptanthrin (Figure 7A). We also observed that the
inhibition of HO-1 induction by SnPP leads to the increase
of nitrite (Figure 7C) and TNF-α (Figure 7D) in tryptanthrin
pretreated BV2 microglia under LPS-induced inflammatory
condition.
DISCUSSION
The present study was undertaken to confirm MCAO injury
triggers the activation of microglia in brain tissue, and to
investigate whether tryptanthrin influences the function of
BV2 microglia under LPS-induced inflammatory conditions
in vitro. The study confirms MCAO induces the activation
of microglia in brain tissue, and shows tryptanthrin reduces
neuroinflammatory response by controlling microglial function.
Taken together, tryptanthrin appears to ameliorate the
pro-inflammatory effects of BV2 microglia and to have
therapeutic potential for the prevention of brain tissue damage
in the presence of neuroinflammatory disease. Ischemic stroke
causes damage by triggering severe inflammation in brain
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FIGURE 6 | Nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase 1 (HO-1) signaling pathway activation in tryptanthrin pre-treated
BV2 microglia. (A) Immunostaining data showing the expression of Nrf2 was greater in tryptanthrin pretreated BV2 microglia than in BV2 microglia treated with LPS
alone. (B) The graph of Nrf2 immunostaining relative intensity in BV2 microglia. (C) Western blotting data showed that the translocation of Nrf2 from cytosol into
nucleus using nucleus fraction. Each experiment conducted four repeats per conditions. Results are expressed as means ± SDs. Results are expressed as
means ± SDs. Significant vs. control, #p < 0.05,##p < 0.01; significant vs. LPS, ∗p < 0.05, ∗∗p < 0.01 (ANOVA analysis). Scale bar: 50 µm,
4′,6-diamidino-2-phenylindole (DAPI): blue, Nrf2: red. Con, non-treated control; LPS, LPS (1 µg/ml) treated cells; TT, tryptanthrin.
(Roger et al., 2012). In ischemic stroke, microglia activate and
promote the productions of inflammatory cytokines and the
activation of inflammatory signaling (Lakhan et al., 2009).
In present study, we confirmed the activation of microglia in
our MCAO model of ischemic stroke (Meng et al., 2016). In
addition, we observed LPS induce inflammation leads to the
induction of M1 phenotype microglia in brain based on the
increased expression of CD68 mannose receptor and iNOS
in brain (Lisi et al., 2014; Meng et al., 2016). M1 phenotype
microglia are associated with the activation of inflammatory
signaling, such as, by NF-κB and iNOS, which promotes the
productions of pro-inflammatory cytokines and could lead
to severe neuropathology and pain (Popiolek-Barczyk et al.,
2015; Meng et al., 2016). Our in vivo data suggest MCAO
injury as an inflammatory injury leads to M1 induction in
brain tissues and trigger the activations of NF-κB and iNOS
inflammatory signaling. Tryptanthrin (a natural alkaloid)
has strong anti-inflammatory effects and has been shown to
protect cells against stressful conditions (Recio et al., 2006;
Iwaki et al., 2011; Pathania et al., 2014; Popov et al., 2015).
We employed BV2 microglia cell line to evaluate the effects
of tryptanthrin on microglia. BV2 microglia cell line derived
from v-raf /v-myc-immortalized murine neonatal microglia
(Blasi et al., 1990) has been frequently used substitute for
primary microglia (Stansley et al., 2012). There are concerns
about suitability of BV2 cells as a sufficient substitute for
primary microglia. However, recent studies have found that
their responses to LPS are similar to primary microglia
on the gene profiling and functional capacities in NO and
cytokine secretion (Horvath et al., 2008; Henn et al., 2009).
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FIGURE 7 | Effects of tryptanthrin on HO-1 expression in BV2 microglia. (A) BV2 microglial cells were incubated with 20 µM tryptanthrin for 0–24 h.
(B) BV2 microglia cells were treated for 8 h with 0.1–20 µM concentrations of tryptanthrin. HO-1 expression was assessed by western blotting using a specific
antibody. Tryptanthrin time- and dose-dependently induced HO-1 expression. β-actin was used as an internal loading control. To examine the inhibitory effects of
tryptanthrin pretreatment and of co-pretreatments with tryptanthrin and SnPP (a HO-1 inhibitor) on the LPS-induced productions of nitrite (C) and TNF-α (D),
BV2 microglia cells were pre-treated with tryptanthrin (20 µM) for 1 h in the presence or absence of SnPP (50 nM, 30 min), and then stimulated with LPS (1 µg/ml)
for 8 h. Each experiment conducted four repeats per conditions. Levels of nitrite and TNF-α are presented as means ± SDs. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001
(ANOVA analysis). Con, non-treated control; TT, tryptanthrin; LPS, LPS 1 µg/ml treatment; SnPP, 50 nM SnPP treatment.
Furthermore, they have suggested that BV2 cells are suitable
to primary microglia and animal experiments due to the price
of the assay and the speed of data generation (Henn et al.,
2009). Our in vitro data confirm tryptanthrin influences the
polarization of BV2 microglia and could reduce the induction
of the M1 phenotype under LPS induced inflammatory
conditions. Furthermore, we found tryptanthrin attenuated
the secretion of NO and the activations of iNOS and COX-2.
Several studies have demonstrated NO plays a crucial role in
promoting inflammatory response (Wang et al., 2007), and that
reactive microglia express iNOS leading to energy depletion
and cell death after ischemic stroke (Samdani et al., 1997;
Saha and Pahan, 2006). We observed tryptanthrin treatment
under inflammatory condition decreased pro-inflammatory
cytokine levels, including those of TNF-α and IL-6. Given
that pro-inflammatory cytokines promote COX-2 and iNOS
transcription (Das and Basu, 2008; Perry et al., 2010), we
believe tryptanthrin may inhibit the activations of COX-2
and iNOS by reducing the secretions of pro-inflammatory
cytokines. Furthermore, our results indicate that tryptanthrin
blocks NF-κB transcriptional activity in BV2 microglia under
inflammation conditions. NF-κB is an important transcription
factor in the regulation of inflammatory response, and its
activation causes cellular death (Camandola and Mattson, 2007).
In addition, NF-κB has been known to suppress the expressions
of iNOS and COX-2 and to activate pro-inflammatory cytokine
secretion (Shin et al., 2002; Atreya et al., 2008; Nam et al., 2010).
Previous studies have demonstrated that inhibition of NF-κB
in mouse brain reduce brain infarct volumes after ischemic
injury (Nurmi et al., 2004; Qin et al., 2007). Although we did
not find tryptanthrin reduced brain infarct volumes in our
MCAO model, we assume that tryptanthrin may have the
potential to attenuate neuropathology of ischemic stroke as an
inflammatory neurodisease by inhibiting NF-κB signaling in
microglia. HO enzymes are known to be crucial components
of the cellular antioxidant system and to be involved in various
diseases, including ischemic stroke (Panahian et al., 1999),
and HO-1 induction by activated Nrf2 (Qiang et al., 2004)
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protects cells against oxidative stress (de Vries et al., 2008).
In addition, HO-1 in microglia has been reported to have
an anti- inflammatory effect (Min et al., 2008), for example,
it inhibits pro-inflammatory cytokine secretion by activated
microglia (Petrache et al., 2000). Furthermore, the expressional
up-regulation of HO-1 was found to reduce the expressions
of pro-inflammatory cytokines and suppress COX-2 and
iNOS levels (Suh et al., 2006). Interestingly, it has also been
demonstrated that tryptanthrin upregulates HO-1 signaling in
hepatocytes (Moon et al., 2014). In present study, tryptanthrin
attenuated the production of pro-inflammatory cytokines
and nitrite in BV2 microglia through Nrf2/HO-1 signaling.
Although we did not examine behavioral improvements or
attempt to quantify brain damage reduction by tryptanthrin in
our MCAO model, the study provides evidence tryptanthrin
might control the function of microglia through Nrf2/HO-
1 and NF-κB signaling, which suggests tryptanthrin could
alleviate neuropathology of neuroinflammatory disease such as
stroke. To confirm these findings, various preclinical studies
need to be performed to investigate the toxicological as well
as the potential preventive or even therapeutic effects of
tryptanthrin.
AUTHOR CONTRIBUTIONS
Y-WK, SYC and SYP conducted the experiments. Y-WK and
SYC contributed to the writing of the first draft of the
manuscript. JS and J-HL designed the study and wrote
the manuscript, and provided overall supervision for the
project.
ACKNOWLEDGMENTS
This work was supported by the Dongguk University Research
Fund (2016).
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fncel.20
17.00018/full#supplementary-material
FIGURE S1 | The atlas of brain position. For this study, we measured
the expressions of CD68 in bregma 0.62 mm of MCAO mouse. This
image is from brain atlas.
REFERENCES
Almada, M., Cunha, S., Fonseca, B. M., Amaral, C., Piscitelli, F., Di
Marzo, V., et al. (2016). Anandamide interferes with human endometrial
stromal-derived cell differentiation: an effect dependent on inhibition of
cyclooxygenase-2 expression and prostaglandin E2 release. Biofactors 42,
277–286. doi: 10.1002/biof.1270
Atreya, I., Atreya, R., and Neurath, M. F. (2008). NF-κB in inflammatory
bowel disease. J. Intern. Med. 263, 591–596. doi: 10.1111/j.1365-2796.2008.
01953.x
Benarroch, E. E. (2013). Microglia: multiple roles in surveillance, circuit
shaping and response to injury. Neurology 81, 1079–1088. doi: 10.1212/WNL.
0b013e3182a4a577
Blasi, E., Barluzzi, R., Bocchini, V., Mazzolla, R., and Bistoni, F. (1990).
Immortalization of murine microglial cells by a v-raf/v-myc carrying
retrovirus. J. Neuroimmunol. 27, 229–237. doi: 10.1016/0165-5728(90)9
0073-v
Boche, D., Perry, V. H., and Nicoll, J. A. (2013). Review: activation patterns
of microglia and their identification in the human brain. Neuropathol. Appl.
Neurobiol. 39, 3–18. doi: 10.1111/nan.12011
Butovsky, O., Siddiqui, S., Gabriely, G., Lanser, A. J., Dake, B., Murugaiyan, G.,
et al. (2012). Modulating inflammatory monocytes with a unique microRNA
gene signature ameliorates murine ALS. J. Clin. Invest. 122, 3063–3087.
doi: 10.1172/JCI62636
Camandola, S., and Mattson, M. P. (2007). NF-κB as a therapeutic target
in neurodegenerative diseases. Expert Opin. Ther. Targets 11, 123–132.
doi: 10.1517/14728222.11.2.123
Cendan, J. C., Topping, D. L., Pruitt, J., Snowdy, S., Copeland, E. M. III., and
Lind, D. S. (1996). Inflammatory mediators stimulate arginine transport and
arginine-derived nitric oxide production in a murine breast cancer cell line.
J. Surg. Res. 60, 284–288. doi: 10.1006/jsre.1996.0044
Cheon, S. Y., Cho, K. J., Song, J., and Kim, G. W. (2016). Knockdown of apoptosis
signal-regulating kinase 1 affects ischaemia-induced astrocyte activation and
glial scar formation. Eur. J. Neurosci. 43, 912–922. doi: 10.1111/ejn.13175
Cherry, J. D., Olschowka, J. A., and O’Banion, M. K. (2014). Neuroinflammation
and M2 microglia: the good, the bad and the inflamed. J. Neuroinflammation
11:98. doi: 10.1186/1742-2094-11-98
Cianciulli, A., Calvello, R., Porro, C., Trotta, T., Salvatore, R., and
Panaro, M. A. (2016). PI3k/Akt signalling pathway plays a crucial role in
the anti-inflammatory effects of curcumin in LPS-activated microglia. Int.
Immunopharmacol. 36, 282–290. doi: 10.1016/j.intimp.2016.05.007
Das, S., and Basu, A. (2008). Inflammation: a new candidate in modulating adult
neurogenesis. J. Neurosci. Res. 86, 1199–1208. doi: 10.1002/jnr.21585
Forman, K., Vara, E., Garcia, C., Kireev, R., Cuesta, S., Acuña-Castroviejo, D.,
et al. (2016). Influence of aging and growth hormone on different members
of the NFkB family and IkB expression in the heart from a murine model of
senescence-accelerated aging. Exp. Gerontol. 73, 114–120. doi: 10.1016/j.exger.
2015.11.005
Gordon, S., and Martinez, F. O. (2010). Alternative activation of macrophages:
mechanism and functions. Immunity 32, 593–604. doi: 10.1016/j.immuni.2010.
05.007
Graeber, M. B., and Streit, W. J. (2010). Microglia: biology and pathology. Acta
Neuropathol. 119, 89–105. doi: 10.1007/s00401-009-0622-0
Hanisch, U. K., and Kettenmann, H. (2007). Microglia: active sensor and versatile
effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387–1394.
doi: 10.1038/nn1997
Henn, A., Lund, S., Hedtjärn, M., Schrattenholz, A., Pörzgen, P., and Leist, M.
(2009). The suitability of BV2 cells as alternative model system for primary
microglia cultures or for animal experiments examining brain inflammation.
ALTEX 26, 83–94. doi: 10.14573/altex.2009.2.83
Honda, G., Tabata, M., and Tsuda, M. (1979). The antimicrobial specificity of
tryptanthrin. Planta Med. 37, 172–174. doi: 10.1055/s-0028-1097320
Honda, G., Tosirisuk, V., and Tabata, M. (1980). Isolation of an
antidermatophytic, tryptanthrin, from indigo plants, polygonum tinctorium
and isatis tinctoria. Planta Med. 38, 275–276. doi: 10.1055/s-2008-10
74877
Horvath, R. J., Nutile-McMenemy, N., Alkaitis, M. S., and Deleo, J. A. (2008).
Differential migration, LPS-induced cytokine, chemokine and NO expression
in immortalized BV-2 and HAPI cell lines and primary microglial cultures.
J. Neurochem. 107, 557–569. doi: 10.1111/j.1471-4159.2008.05633.x
Ishihara, T., Kohno, K., Ushio, S., Iwaki, K., Ikeda, M., and Kurimoto, M.
(2000). Tryptanthrin inhibits nitric oxide and prostaglandin E(2) synthesis by
murine macrophages. Eur. J. Pharmacol. 407, 197–204. doi: 10.1016/s0014-
2999(00)00674-9
Ito, D., Tanaka, K., Suzuki, S., Dembo, T., and Fukuuchi, Y. (2001). Enhanced
expression of Iba1, ionized calcium-binding adapter molecule 1, after transient
focal cerebral ischemia in rat brain. Stroke 32, 1208–1215. doi: 10.1161/01.str.
32.5.1208
Frontiers in Cellular Neuroscience | www.frontiersin.org 10 February 2017 | Volume 11 | Article 18
Kwon et al. The Effects of Tryptanthrin on Microglia
Iwaki, K., Ohashi, E., Arai, N., Kohno, K., Ushio, S., Taniguchi, M., et al. (2011).
Tryptanthrin inhibits Th2 development and IgE-mediated degranulation and
IL-4 production by rat basophilic leukemia RBL-2H3 cells. J. Ethnopharmacol.
134, 450–459. doi: 10.1016/j.jep.2010.12.041
Kettenmann, H., Hanisch, U. K., Noda,M., andVerkhratsky, A. (2011). Physiology
of microglia. Physiol. Rev. 91, 461–553. doi: 10.1152/physrev.00011.2010
Kimoto, T., Hino, K., Koya-Miyata, S., Yamamoto, Y., Takeuchi, M., Nishizaki, Y.,
et al. (2001). Cell differentiation and apoptosis of monocytic and promyelocytic
leukemia cells (U-937 and HL-60) by tryptanthrin, an active ingredient of
polygonum tinctorium lour. Pathol. Int. 51, 315–325. doi: 10.1046/j.1440-1827.
2001.01204.x
Lakhan, S. E., Kirchgessner, A., and Hofer, M. (2009). Inflammatory
mechanisms in ischemic stroke: therapeutic approaches. J. Transl. Med.
7:97. doi: 10.1186/1479-5876-7-97
Liao, X., Zhou, X., Mak, N. K., and Leung, K. N. (2013). Tryptanthrin inhibits
angiogenesis by targeting the VEGFR2-mediated ERK1/2 signalling pathway.
PLoS One 8:e82294. doi: 10.1371/journal.pone.0082294
Lisi, L., Stigliano, E., Lauriola, L., Navarra, P., and Dello Russo, C. (2014).
Proinflammatory-activated glioma cells induce a switch in microglial
polarization and activation status, from a predominant M2b phenotype
to a mixture of M1 and M2a/B polarized cells. ASN Neuro 6, 171–183.
doi: 10.1042/AN20130045
Loane, D. J., Kumar, A., Stoica, B. A., Cabatbat, R., and Faden, A. I. (2014).
Progressive neurodegeneration after experimental brain trauma: association
with chronic microglial activation. J. Neuropathol. Exp. Neurol. 73, 14–29.
doi: 10.1097/NEN.0000000000000021
Mach, F., Schönbeck, U., Fabunmi, R. P., Murphy, C., Atkinson, E.,
Bonnefoy, J. Y., et al. (1999). T lymphocytes induce endothelial cell matrix
metalloproteinase expression by a CD40L-dependent mechanism: implications
for tubule formation. Am. J. Pathol. 154, 229–238. doi: 10.1016/s0002-9440(10)
65269-8
Mazzio, E. A., Li, N., Bauer, D., Mendonca, P., Taka, E., Darb, M., et al.
(2016). Natural product HTP screening for antibacterial (E.coli 0157:H7) and
anti-inflammatory agents in (LPS from E. coli O111:B4) activated macrophages
and microglial cells; focus on sepsis. BMC Complement. Altern. Med. 16:467.
doi: 10.1186/s12906-016-1429-x
Meng, H. L., Li, X. X., Chen, Y. T., Yu, L. J., Zhang, H., Lao, J. M., et al. (2016).
Neuronal soluble fas ligand drives M1-microglia polarization after cerebral
ischemia. CNS Neurosci. Ther. 22, 771–781. doi: 10.1111/cns.12575
Min, K. J., Kim, J. H., Jou, I., and Joe, E. H. (2008). Adenosine induces
hemeoxygenase-1 expression in microglia through the activation of
phosphatidylinositol 3-kinase and nuclear factor E2-related factor 2. Glia
56, 1028–1037. doi: 10.1002/glia.20676
Moon, S. Y., Lee, J. H., Choi, H. Y., Cho, I. J., Kim, S. C., and Kim, Y. W. (2014).
Tryptanthrin protects hepatocytes against oxidative stress via activation of
the extracellular signal-regulated kinase/NF-E2-related factor 2 pathway. Biol.
Pharm. Bull. 37, 1633–1640. doi: 10.1248/bpb.b14-00363
More, S. V., Kumar, H., Kim, I. S., Koppulla, S., Kim, B. W., and Choi, D. K.
(2013). Strategic selection of neuroinflammatorymodels in Parkinson’s disease:
evidence from experimental studies. CNS Neurol. Disord. Drug Targets 12,
680–697. doi: 10.2174/18715273113129990059
Nam, S. J., Gaudencio, S. P., Kauffman, C. A., Jensen, P. R., Kondratyuk, T. P.,
Marler, L. E., et al. (2010). Fijiolides A and B, inhibitors of TNF-α-induced
NFκB activation, from a marine-derived sediment bacterium of the genus
Nocardiopsis. J. Nat. Prod. 73, 1080–1086. doi: 10.1021/np100087c
Nurmi, A., Vartiainen, N., Pihlaja, R., Goldsteins, G., Yrjänheikki, J., and
Koistinaho, J. (2004). Pyrrolidine dithiocarbamate inhibits translocation of
nuclear factor kappa-B in neurons and protects against brain ischaemia with a
wide therapeutic time window. J. Neurochem. 91, 755–765. doi: 10.1111/j.1471-
4159.2004.02756.x
Panahian, N., Yoshiura, M., and Maines, M. D. (1999). Overexpression of heme
oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery
occlusion in transgenicmice. J. Neurochem. 72, 1187–1203. doi: 10.1111/j.1471-
4159.1999.721187.x
Pathania, A. S., Kumar, S., Guru, S. K., Bhushan, S., Sharma, P. R., Aithagani, S. K.,
et al. (2014). The synthetic tryptanthrin analogue suppresses STAT3 signaling
and induces caspase dependent apoptosis via ERK up regulation in human
leukemia HL-60 cells. PLoS One 9:e110411. doi: 10.1371/journal.pone.0110411
Perego, C., Fumagalli, S., and De Simoni, M. G. (2011). Temporal pattern of
expression and colocalization of microglia/macrophage phenotype markers
following brain ischemic injury in mice. J. Neuroinflammation 8:174.
doi: 10.1186/1742-2094-8-174
Perry, V. H., Nicoll, J. A., and Holmes, C. (2010). Microglia in neurodegenerative
disease. Nat. Rev. Neurol. 6, 193–201. doi: 10.1038/nrneurol.2010.17
Petrache, I., Otterbein, L. E., Alam, J., Wiegand, G. W., and Choi, A. M. (2000).
Heme oxygenase-1 inhibits TNF-α-induced apoptosis in cultured fibroblasts.
Am. J. Physiol. Lung Cell. Mol. Physiol. 278, L312–L319.
Picascia, A., Grimaldi, V., Iannone, C., Soricelli, A., and Napoli, C. (2015). Innate
and adaptive immune response in stroke: focus on epigenetic regulation.
J. Neuroimmunol. 289, 111–120. doi: 10.1016/j.jneuroim.2015.10.013
Popiolek-Barczyk, K., Kolosowska, N., Piotrowska, A., Makuch, W., Rojewska, E.,
Jurga, A. M., et al. (2015). Parthenolide relieves pain and promotes
M2 Microglia/Macrophage polarization in rat model of neuropathy. Neural
Plast. 2015:676473. doi: 10.1155/2015/676473
Popov, A. M., Osipov, A. N., Korepanova, E. A., Krivoshapko, O. N., Shtoda, Y. P.,
and Klimovich, A. A. (2015). Study of antioxidant and membranotropic
activities of quinazoline alkaloid tryptanthrin using different model systems.
Biofizika 60, 700–707.
Prinz, M., and Priller, J. (2014). Microglia and brain macrophages in the molecular
age: from origin to neuropsychiatric disease. Nat. Rev. Neurosci. 15, 300–312.
doi: 10.1038/nrn3722
Qiang, W., Cahill, J. M., Liu, J., Kuang, X., Liu, N., Scofield, V. L., et al. (2004).
Activation of transcription factor Nrf-2 and its downstream targets in response
to moloney murine leukemia virus ts1-induced thiol depletion and oxidative
stress in astrocytes. J. Virol. 78, 11926–11938. doi: 10.1128/jvi.78.21.11926-
11938.2004
Qin, L., Liu, Y., Hong, J. S., and Crews, F. T. (2013). NADPH oxidase
and aging drive microglial activation, oxidative stress and dopaminergic
neurodegeneration following systemic LPS administration. Glia 61, 855–868.
doi: 10.1002/glia.22479
Qin, Z.-H., Tao, L.-Y., and Chen, X. (2007). Dual roles of NF-κB in cell survival and
implications of NF-κB inhibitors in neuroprotective therapy. Acta Pharmacol.
Sin. 28, 1859–1872. doi: 10.1111/j.1745-7254.2007.00741.x
Recio, M. C., Cerdá-Nicolás, M., Potterat, O., Hamburger, M., and Ríos, J. L.
(2006). Anti-inflammatory and antiallergic activity in vivo of lipophilic Isatis
tinctoria extracts and tryptanthrin. Planta Med. 72, 539–546. doi: 10.1055/s-
2006-947177
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D.,
Borden, W. B., et al. (2012). Heart disease and stroke statistics–2012 update:
a report from the American heart association. Circulation 125, e2–e220.
doi: 10.1161/CIR.0b013e31823ac046
Rupalla, K., Allegrini, P. R., Sauer, D., and Wiessner, C. (1998). Time
course of microglia activation and apoptosis in various brain regions after
permanent focal cerebral ischemia in mice. Acta Neuropathol. 96, 172–178.
doi: 10.1007/s004010050878
Saha, R. N., and Pahan, K. (2006). Regulation of inducible nitric oxide synthase
gene in glial cells. Antioxid. Redox Signal. 8, 929–947. doi: 10.1089/ars.2006.
8.929
Samdani, A. F., Dawson, T. M., and Dawson, V. L. (1997). Nitric oxide synthase in
models of focal ischemia. Stroke 28, 1283–1288. doi: 10.1161/01.str.28.6.1283
Scovill, J., Blank, E., Konnick, M., Nenortas, E., and Shapiro, T. (2002).
Antitrypanosomal activities of tryptanthrins. Antimicrob. Agents Chemother.
46, 882–883. doi: 10.1128/aac.46.3.882-883.2002
Shin, W. S., Szuba, A., and Rockson, S. G. (2002). The role of chemokines in
human cardiovascular pathology: enhanced biological insights. Atherosclerosis
160, 91–102. doi: 10.1016/s0021-9150(01)00571-8
Shu, Z. M., Shu, X. D., Li, H. Q., Sun, Y., Shan, H., Sun, X. Y., et al. (2016).
Ginkgolide B protects against ischemic stroke via modulating microglia
polarization in mice. CNS Neurosci. Ther. 22, 729–739. doi: 10.1111/cns.12577
Smolewski, P., Bedner, E., Gorczyca, W., and Darzynkiewicz, Z. (2001).
‘‘Liquidless’’ cell staining by dye diffusion from gels and analysis by laser
scanning cytometry: potential application at microgravity conditions in space.
Cytometry 44, 355–360. doi: 10.10.1002/1097-0320 (20010801)44:4<355::AID-
CYTO1127>3.0.CO;2-W
Song, J., Cheon, S. Y., Jung, W., Lee, W. T., and Lee, J. E. (2014). Resveratrol
induces the expression of interleukin-10 and brain-derived neurotrophic
Frontiers in Cellular Neuroscience | www.frontiersin.org 11 February 2017 | Volume 11 | Article 18
Kwon et al. The Effects of Tryptanthrin on Microglia
factor in BV2 microglia under hypoxia. Int. J. Mol. Sci. 15, 15512–15529.
doi: 10.3390/ijms150915512
Song, J., and Lee, J. E. (2015). ASK1 modulates the expression of microRNA Let7A
in microglia under high glucose in vitro condition. Front. Cell. Neurosci. 9:198.
doi: 10.3389/fncel.2015.00198
Stansley, B., Post, J., and Hensley, K. (2012). A comparative review of cell
culture systems for the study of microglial biology in Alzheimer’s disease.
J. Neuroinflammation 9:115. doi: 10.1186/1742-2094-9-115
Streit, W. J., Mrak, R. E., and Griffin, W. S. (2004). Microglia and
neuroinflammation: a pathological perspective. J. Neuroinflammation 1:14.
doi: 10.1385/1-59259-297-x:003
Suh, S. J., Chung, T.W., Son,M. J., Kim, S. H., Moon, T. C., Son, K. H., et al. (2006).
The naturally occurring biflavonoid, ochnaflavone, inhibits LPS-induced
iNOS expression, which is mediated by ERK1/2 via NF-κB regulation, in
RAW264.7 cells. Arch. Biochem. Biophys. 447, 136–146. doi: 10.1016/j.abb.
2006.01.016
Tang, Y., and Le, W. (2016). Differential roles of M1 and M2 microglia
in neurodegenerative diseases. Mol. Neurobiol. 53, 1181–1194.
doi: 10.1007/s12035-014-9070-5
Thored, P., Heldmann, U., Gomes-Leal, W., Gisler, R., Darsalia, V.,
Taneera, J., et al. (2009). Long-term accumulation of microglia with
proneurogenic phenotype concomitant with persistent neurogenesis in
adult subventricular zone after stroke. Glia 57, 835–849. doi: 10.1002/glia.
20810
de Vries, H. E., Witte, M., Hondius, D., Rozemuller, A. J., Drukarch, B.,
Hoozemans, J., et al. (2008). Nrf2-induced antioxidant protection: a promising
target to counteract ROS-mediated damage in neurodegenerative disease? Free
Radic. Biol. Med. 45, 1375–1383. doi: 10.1016/j.freeradbiomed.2008.09.001
Wang, Q., Tang, X. N., and Yenari, M. A. (2007). The inflammatory
response in stroke. J. Neuroimmunol. 184, 53–68. doi: 10.1016/j.jneuroim.2006.
11.014
Wang, X. J., Xiong, G. P., Luo, X. M., Huang, S. Z., Liu, J., Huang, X. L., et al.
(2016). Dibutyl phthalate inhibits the effects of follicle-stimulating hormone
on rat granulosa cells through down-regulation of follicle-stimulating hormone
receptor. Biol. Reprod. 94:144. doi: 10.1095/biolreprod.115.136002
Wang, G., Zhang, J., Hu, X., Zhang, L., Mao, L., Jiang, X., et al. (2013).
Microglia/macrophage polarization dynamics in white matter after traumatic
brain injury. J. Cereb. Blood Flow Metab. 33, 1864–1874. doi: 10.1038/jcbfm.
2013.146
Yu, S. T., Chen, T. M., Chern, J. W., Tseng, S. Y., and Chen, Y. H. (2009).
Downregulation of GSTpi expression by tryptanthrin contributing to
sensitization of doxorubicin-resistant MCF-7 cells through c-jun NH2-
terminal kinase-mediated apoptosis. Anticancer Drugs 20, 382–388.
doi: 10.1097/CAD.0b013e32832a2cd4
Yu, S. T., Chen, T. M., Tseng, S. Y., and Chen, Y. H. (2007). Tryptanthrin inhibits
MDR1 and reverses doxorubicin resistance in breast cancer cells. Biochem.
Biophys. Res. Commun. 358, 79–84. doi: 10.1016/j.bbrc.2007.04.107
Zhang, D., Liu, H., Zeng, J., Miao, X., Huang, W., Chen, H., et al. (2016).
Glucocorticoid exposure in early placentation induces preeclampsia in rats
via interfering trophoblast development. Gen. Comp. Endocrinol. 225, 61–70.
doi: 10.1016/j.ygcen.2015.09.019
Zhang, Q., Yuan, L., Zhang, Q., Gao, Y., Liu, G., Xiu, M., et al. (2015).
Resveratrol attenuates hypoxia-induced neurotoxicity through inhibiting
microglial activation. Int. Immunopharmacol. 28, 578–587. doi: 10.1016/j.
intimp.2015.07.027
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Kwon, Cheon, Park, Song and Lee. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution and reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Cellular Neuroscience | www.frontiersin.org 12 February 2017 | Volume 11 | Article 18
